Sintx Technologies, Inc. (SINT)
NASDAQ: SINT · Real-Time Price · USD
2.930
-0.140 (-4.56%)
Nov 4, 2024, 4:00 PM EST - Market closed
Company Description
Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States.
It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone.
The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
Sintx Technologies, Inc.
Country | United States |
Founded | 1996 |
IPO Date | Feb 13, 2014 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 43 |
CEO | Eric Olson |
Contact Details
Address: 1885 West 2100 South Salt Lake City, Utah 84119 United States | |
Phone | 801 839 3500 |
Website | sintx.com |
Stock Details
Ticker Symbol | SINT |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001269026 |
CUSIP Number | 829392307 |
ISIN Number | US8293926049 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Eric K. Olson | President, Chief Executive Officer and Director |
Dr. Ryan Bock Ph.D. | Chief Technology Officer |
Ann Kutsch | President of SINTX Technology Assessment and Transfer |
Gina Moss | Director of Operations |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Nov 1, 2024 | 8-K | Current Report |
Sep 26, 2024 | 8-K | Current Report |
Aug 13, 2024 | 10-Q | Quarterly Report |
Aug 6, 2024 | 8-K | Current Report |
Jul 11, 2024 | 8-K | Current Report |
Jul 11, 2024 | 424B5 | Filing |
Jun 12, 2024 | 8-K | Current Report |
May 23, 2024 | 8-K | Current Report |
May 15, 2024 | 8-K | Current Report |
May 13, 2024 | 10-Q | Quarterly Report |